"Further, while we acknowledge the corrective and preventive actions that your site has taken or plans to take, your written response is inadequate because it does not provide sufficient details about how you, as a clinical investigator, will ensure adequate oversight of the study procedures (for example, adherence to eligibility requirements)
These results may help provide context for how your individual genetic background relates to GLP-1 pathway sensitivity and therapeutic response, supporting more informed conversations with your provider about personalized dosing strategies
Impact on body weight regulation and lipid homeostasis Increased BMI is linearly and positively associated with the risk of organ-specific tumors [52, 53]
Avoid heavy, greasy, or very sugary foods on injection day
It was a deep dive into all the poison center calls involving GLP-1 agonists made to the Rocky Mountain Poison and Drug Safety Center in Denver from January 2014 to May 2023
One Study participants reported mild to moderate gastrointestinal (GI) problems as the most common side effects they experienced